4.8 Article

Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation

Journal

NATURE
Volume 510, Issue 7503, Pages 157-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nature13199

Keywords

-

Funding

  1. National Institutes of Health (NIH) [AI069259, AI078897, AI095261, AI111595]
  2. NIH [5F31AR063546-02]
  3. Human Frontiers Science Program
  4. Charles A. King Trust
  5. National Psoriasis Foundation
  6. BBSRC [BB/F000227/1] Funding Source: UKRI
  7. MRC [G0901905] Funding Source: UKRI
  8. Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish
  9. Medical Research Council [G0901905] Funding Source: researchfish
  10. Wellcome Trust [101054/Z/13/Z] Funding Source: researchfish

Ask authors/readers for more resources

The skin has a dual function as a barrier and a sensory interface between the body and the environment. To protect against invading pathogens, the skin harbours specialized immune cells, including dermal dendritic cells (DDCs) and interleukin (IL)-17-producing gamma delta T (gamma delta T17) cells, the aberrant activation of which by IL-23 can provoke psoriasis-like inflammation(1-4). The skin is also innervated by a meshwork of peripheral nerves consisting of relatively sparse autonomic and abundant sensory fibres. Interactions between the autonomic nervous system and immune cells in lymphoid organs are known to contribute to systemic immunity, but how peripheral nerves regulate cutaneous immune responses remains unclear(5,6). We exposed the skin of mice to imiquimod, which induces IL-23-dependent psoriasis-like inflammation(7,8). Hereweshowthat a subset of sensory neurons expressing the ion channels TRPV1 and Na(v)1.8 is essential to drive this inflammatory response. Imaging of intact skin revealed that a large fraction of DDCs, the principal source of IL-23, is in close contact with these nociceptors. Upon selective pharmacological or genetic ablation of nociceptors(9-11), DDCs failed to produce IL-23 in imiquimod-exposed skin. Consequently, the local production of IL-23-dependent inflammatory cytokines by dermal gamma delta T17 cells and the subsequent recruitment of inflammatory cells to the skin were markedly reduced. Intradermal injection of IL-23 bypassed the requirement for nociceptor communicationwithDDCs and restored the inflammatory response(12). These findings indicate that TRPV1(+)Na(v)1.8(+) nociceptors, by interacting with DDCs, regulate the IL-23/IL-17 pathway andcontrol cutaneousimmune responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available